Leerink Partners Initiates Coverage On Dentsply Sirona with Outperform Rating, Announces Price Target of $42
Portfolio Pulse from Benzinga Newsdesk
Leerink Partners analyst Michael Cherny initiates coverage on Dentsply Sirona (XRAY) with an Outperform rating and a price target of $42.

February 26, 2024 | 1:26 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Leerink Partners initiated coverage on Dentsply Sirona with an Outperform rating and a price target of $42.
The initiation of coverage by Leerink Partners with an Outperform rating and a price target of $42 is a strong positive signal for Dentsply Sirona. Analyst ratings, especially with an Outperform status, can influence investor perception and potentially drive the stock price up in the short term. The specific mention of a $42 price target suggests a bullish outlook from the analyst, which could further encourage buying activity among investors.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100